GlaxoSmithKline | GSK - Debt

Stock Price
2,144.00
Daily Change
37.00 1.76%
Monthly
1.04%
Yearly
46.30%
Q2 Forecast
2,097.48

GlaxoSmithKline reported GBP17.75B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Alcon AG USD 509M 4.74B Dec/2025
Almirall EUR 342.86M 61.94M Dec/2025
Amgen USD 54.59B 1.62B Sep/2025
argenx SE USD 43.15M 4.1M Jun/2025
AstraZeneca USD 32.63B 207M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Biogen USD 6.29B 1.7M Dec/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Fresenius EUR 12.85B 778M Jun/2025
Fresenius Medical Care EUR 10.8B 322.94M Dec/2025
Galapagos EUR 7.5M 3.36M Sep/2025
Genmab DKK 148M 5M Jun/2025
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Glaxosmithkline GBP 17.75B 396M Sep/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 12.1B 2.7B Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Orion EUR 305.4M 15.8M Dec/2025
Pfizer USD 60.85B 78M Sep/2025
Philips EUR 8.38B 41M Sep/2025
Recordati EUR 2.5B 33.23M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
Smith & Nephew USD 3.32B 334M Dec/2024
UCB EUR 3.03B 12M Dec/2024